PWAM
TRIB

Park West Asset Management’s Trinity Biotech TRIB Stock Holding History

Park West Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,689
Closed -$11.3M – 70
2016
Q3 		$11.3M Sell
5,689
-311
-5% -$581K 1.03% 30
2016
Q2 		$10.2M Hold
6,000
– – 1.03% 33
2016
Q1 		$10.5M Buy
6,000
+2,322
+63% +$3.7M 0.99% 31
2015
Q4 		$6.49M Sell
3,678
-36
-1% -$63.7K 0.7% 40
2015
Q3 		$6.37M Sell
3,714
-1,414
-28% -$3.41M 0.58% 49
2015
Q2 		$13.9M Buy
5,128
+641
+14% +$1.66M 1.29% 26
2015
Q1 		$13M Buy
4,487
+79
+2% +$219K 1.89% 21
2014
Q4 		$11.6M Buy
4,408
+403
+10% +$1.04M 1.84% 21
2014
Q3 		$11M Buy
4,005
+533
+15% +$1.73M 1.62% 20
2014
Q2 		$12M Buy
3,472
+250
+8% +$889K 1.57% 22
2014
Q1 		$11.7M Sell
3,222
-166
-5% -$653K 1.33% 23
2013
Q4 		$12.8M Buy
3,388
+166
+5% +$598K 1.62% 22
2013
Q3 		$10.5M Buy
3,222
+233
+8% +$681K 1.56% 19
2013
Q2 		$7.56M Buy
+2,989
New +$7.44M 0.89% 37

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Park West Asset Management's TRIB Position: Q4 2016 in Review

Park West Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 5,689 shares — an estimated $11.3M sold.

Park West Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $13.9M in Q2 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Park West Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Park West Asset Management sold 5,689 Trinity Biotech shares in Q4 2016, an estimated $11.3M.
  • Park West Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Park West Asset Management's Trinity Biotech position peaked at $13.9M in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Park West Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.